ID   G549
AC   CVCL_C9A4
SY   G549NS
DR   Wikidata; Q123031339
RX   DOI=10.1021/acsmaterialsau.3c00029;
RX   PubMed=30995489;
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   DOI=10.1021/acsmaterialsau.3c00029;
RA   Smith L.J., Skirzynska A., Chin A.A., Arnold A.E., Kushida M.M.,
RA   Dirks P.B., Shoichet M.S.;
RT   "Engineered in vitro tumor model recapitulates molecular signatures of
RT   invasion in glioblastoma.";
RL   ACS Materials Au 3:514-527(2023).
//
RX   PubMed=30995489; DOI=10.1016/j.celrep.2019.03.047;
RA   MacLeod G., Bozek D.A., Rajakulendran N., Monteiro V., Ahmadi M.,
RA   Steinhart Z., Kushida M.M., Yu H., Coutinho F.J., Cavalli F.M.G.,
RA   Restall I.J., Hao X.-G., Hart T., Luchman H.A., Weiss S., Dirks P.B.,
RA   Angers S.;
RT   "Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and
RT   mechanisms of temozolomide sensitivity in glioblastoma stem cells.";
RL   Cell Rep. 27:971-986.e9(2019).
//
RX   PubMed=36989359; DOI=10.1126/sciadv.ade5321; PMCID=PMC10058241;
RA   Wang X., Gong Z.-Y., Wang T.-C., Law J.-H., Chen X., Wanggou S.-Y.,
RA   Wang J.-T., Ying B.-B., Francisco M.A., Dong W.-F., Xiong Y., Fan J.J.,
RA   MacLeod G., Angers S., Li X.-J., Dirks P.B., Liu X.-Y., Huang X.,
RA   Sun Y.;
RT   "Mechanical nanosurgery of chemoresistant glioblastoma using
RT   magnetically controlled carbon nanotubes.";
RL   Sci. Adv. 9:eade5321.1-eade5321.14(2023).
//